Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiovascular Disease
100%
Postmenopausal Women
100%
Hormone Therapy
100%
Hormone Replacement Therapy
100%
Primary Prevention
44%
Secondary Prevention
44%
Risk Ratio
44%
Cardiovascular Disease Events
33%
Placebo
22%
Pulmonary Embolism
22%
Stroke Risk
22%
Venous Thromboembolic Events
22%
Cardiovascular Prevention
22%
Gabriel
11%
Beneficial Effects
11%
Meta-analysis
11%
Single Treatment
11%
Randomized Controlled Trial
11%
Event Risk
11%
Therapy Treatment
11%
Protective Effect
11%
Regression Analysis
11%
Confidence Interval
11%
Extracted Data
11%
No Significant Difference
11%
Stratified Analysis
11%
Fixed Effects
11%
All-cause Mortality
11%
Venous Thromboembolism
11%
Non-fatal
11%
Selection Criteria
11%
Potential Predictors
11%
Cardiovascular Mortality
11%
MEDLINE
11%
Cochrane Library
11%
Cochrane Collaboration
11%
Embase
11%
Time Effect
11%
Differential Effects
11%
Search Methods
11%
Cochrane Review
11%
Orally Administered
11%
Coronary Artery
11%
Combination Treatment
11%
Time-to-treatment
11%
Cardiovascular Outcomes
11%
Number Needed to Harm
11%
Single Therapy
11%
Menopausal Symptoms
11%
Angina
11%
Follow-up Treatment
11%
Angioplasty
11%
Cochrane Central Register of Controlled Trials
11%
Risk Factors for Cardiovascular Diseases
11%
New Trial
11%
Lowest Effective Dose
11%
Combined Risk
11%
Secondary Prevention of Cardiovascular Diseases
11%
Predisposing Risk Factors
11%
Associated numbers
11%
Medicine and Dentistry
Cardiovascular Disease
100%
Hormone Therapy
100%
Postmenopause
100%
Hormone Substitution
100%
Primary Prevention
55%
Secondary Prevention
55%
Apoplexy
33%
Pulmonary Embolism
22%
Thromboembolism
22%
Placebo
22%
Meta-Analysis
11%
Venous Thromboembolism
11%
All Cause Mortality
11%
Observational Study
11%
Angioplasty
11%
Coronary Artery
11%
Number Needed to Harm
11%
Menopausal Symptom
11%
Meta-Regression
11%
Arm
11%
Randomized Controlled Trial
11%
Systematic Review
11%
Angina pectoris
11%
Nursing and Health Professions
Hormonal Therapy
100%
Cardiovascular Disease
100%
Hormone Substitution
100%
Secondary Prevention
55%
Primary Prevention
55%
Cerebrovascular Accident
33%
Cochrane Library
22%
Lung Embolism
22%
Placebo
22%
Thromboembolism
22%
Meta Analysis
11%
Systematic Review
11%
Confidence Interval
11%
Venous Thromboembolism
11%
All Cause Mortality
11%
Angioplasty
11%
Number Needed to Harm
11%
Pharmacology, Toxicology and Pharmaceutical Science
Replacement Therapy
100%
Endocrine Therapy
100%
Cardiovascular Disease
100%
Cerebrovascular Accident
33%
Placebo
22%
Lung Embolism
22%
Thromboembolism
22%
Observational Study
11%
Randomized Controlled Trial
11%
Venous Thromboembolism
11%
All Cause Mortality
11%
Number Needed to Harm
11%